Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.

PURPOSE We determined whether the association between breast density and breast cancer risk and cancer severity differs according to menopausal status and postmenopausal hormone therapy (HT) use. METHODS We collected data on 587,369 women who underwent 1,349,027 screening mammography examinations; 14,090 women were diagnosed with breast cancer. We calculated 5-year breast cancer risk from a survival model for subgroups of women classified by their Breast Imaging Reporting and Data System (BIRADS) breast density, age, menopausal status, and current HT use, assuming a body mass index of 25 kg/m(2). Odds of advanced (ie, IIb, III, IV) versus early (ie, I, IIa) stage invasive cancer was calculated according to BIRADS density. RESULTS Breast cancer risk was low among women with low density (BIRADS-1): women age 55 to 59 years, 5-year risk was 0.8% (95% CI, 0.6 to 0.9%) for non-HT users and 0.9% (95% CI, 0.7% to 1.1%) for estrogen and estrogen plus progestin users. Breast cancer risk was high among women with very high density (BIRADS-4), particularly estrogen plus progestin users: women age 55 to 59 years, 5-year risk was 2.4% (95% CI, 2.0% to 2.8%) for non-HT users, 3.0% (95% CI, 2.6% to 3.5%) for estrogen users, and 4.2% (95% CI, 3.7% to 4.6%) for estrogen plus progestin users. Advanced-stage breast cancer risk was increased 1.7-fold for postmenopausal HT users who had very high density (BIRADS-4) compared to those with average density (BIRADS-2). CONCLUSION Postmenopausal women with high breast density are at increased risk of breast cancer and should be aware of the added risk of taking HT, especially estrogen plus progestin.

[1]  S. Duffy,et al.  Size, node status and grade of breast tumours: association with mammographic parenchymal patterns , 2000, European Radiology.

[2]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[3]  S. Duffy,et al.  Change in breast density as a biomarker of breast cancer risk reduction; results from IBIS-1 , 2009 .

[4]  S. Ciatto,et al.  Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. , 2005, Breast.

[5]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[6]  Romayne A. Thompson,et al.  Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.

[7]  K. Kerlikowske,et al.  Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. , 1997, AJR. American journal of roentgenology.

[8]  B. Geller,et al.  A prospective study of breast cancer risk using routine mammographic breast density measurements. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  K. Kerlikowske,et al.  Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. , 1998, Journal of the National Cancer Institute.

[10]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[11]  Garnet L Anderson,et al.  Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. , 2006, JAMA.

[12]  Diederick E Grobbee,et al.  Postmenopausal hormone therapy and changes in mammographic density. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Gary R Cutter,et al.  Association between mammography timing and measures of screening performance in the United States. , 2005, Radiology.

[14]  N. Boyd,et al.  Mammographic Density as a Surrogate Marker for the Effects of Hormone Therapy on Risk of Breast Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[15]  Karla Kerlikowske,et al.  Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model , 2008, Annals of Internal Medicine.

[16]  D. Miglioretti,et al.  Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Opper,et al.  HERITABILITY OF MAMMOGRAPHIC DENSITY, A RISK FACTOR FOR BREAST CANCER , 2002 .

[18]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[19]  S. Taplin,et al.  Reproductive and hormonal factors associated with mammographic breast density by age (United States) , 2000, Cancer Causes & Control.

[20]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[21]  C. Y. Wang,et al.  Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  R. Langer,et al.  Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial , 2003 .

[23]  K. Kerlikowske,et al.  Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.

[24]  R. Langer,et al.  Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. , 2003, JAMA.

[25]  Emily White,et al.  Association between Mammographic Breast Density and Breast Cancer Tumor Characteristics , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  J. Russo,et al.  Influence of age and parity on the development of the human breast , 2005, Breast Cancer Research and Treatment.

[27]  Yingye Zheng,et al.  Partly Conditional Survival Models for Longitudinal Data , 2005, Biometrics.

[28]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[29]  Celine M Vachon,et al.  Case-control study of increased mammographic breast density response to hormone replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  Michael J. Carston,et al.  Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[31]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[32]  M. Rousseau.  Hormone replacement therapy. , 1998, Nurse practitioner forum.

[33]  L W Bassett,et al.  Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. , 1999, Annals of internal medicine.

[34]  Mark A Helvie,et al.  Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. , 2004, Radiology.

[35]  Beth A Reboussin,et al.  Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.

[36]  Andrew J Evans,et al.  Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. , 2007, AJR. American journal of roentgenology.

[37]  Norman Boyd,et al.  The Association of Measured Breast Tissue Characteristics with Mammographic Density and Other Risk Factors for Breast Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[38]  Lee-Jen Wei,et al.  Cox-Type Regression Analysis for Large Numbers of Small Groups of Correlated Failure Time Observations , 1992 .